Koro, i'm not going to disagree with you but my question remains, whether i'm being delusional or not.
If this is in fact the FDA phase 4 trial information they are after, is it done after the product hits the market?
The way Starpharma writes the announcment it seems like it is required prior to getting marketing approval.
If I find out there is a hope for the product to hit the market prior to this data needing to be submitted I may remove my sell orders but until then this looks bad.
Koro, i'm not going to disagree with you but my question...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55099 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 65000 | 1 |
View Market Depth
| Last trade - 11.15am 25/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable